ABSTRACT BACKGROUND: Ranson's criteria are widely used to evaluate severity of acute pancreatitis (AP). Red blood cell distribution width (RDW) has been demonstrated to be useful marker to predict mortality in these patients. The aim of the present study was to investigate correlation between Ranson score and RDW in patients with AP.
Complete blood count (CBC) is a laboratory test frequently used in clinical practice, and comprises white blood cell, red blood cell, and platelet counts, and their morphological indices, such as red blood cell distribution width (RDW). RDW measures size variability of erythrocytes. It is used to differentiate etiology of anemia, and in a previous study, RDW was demonstrated to be useful marker for predicting mortality in AP patients. [1, 2] The present study is investigation of correlation between RDW and Ranson score in group of AP patients.
MATERIALS AND METHODS

Patients
A total of 202 patients with AP treated between January 2012 and December 2014 were included in the study. AP was diagnosed with typical physical examination findings associated with plasma amylase level ≥3 times upper limit of normal level and radiological verification of disease with ultrasonography and/or abdominal tomography. AP was classified as mild or severe based on presence of organ failure for more than
INTRODUCTION
Acute pancreatitis (AP) is an acute inflammatory disease, and is one of the most frequent gastrointestinal causes of hospital admission. Prognosis of AP depends on its severity, which can be classified as mild or severe, according to latest revised Atlanta Classification. Majority of patients have mild, self-limited disease; however, approximately 20% of patients have severe form. Early assessment of severity is fundamental.
Several single and multiparameter predictors to evaluate severity of the disease have been described. Ranson criteria are widely used in clinical practice worldwide, but this scoring system has limitation that evaluation cannot be completed 48 hours and/or local complications, according to Atlanta criteria. [3] Organ failure included shock (systolic blood pressure <90 mmHg), pulmonary insufficiency (arterial partial pressure of oxygen <60 mmHg at room air or need for mechanical ventilation), or renal failure (serum creatinine level >2 mg/dL after rehydration or hemodialysis).
Demographic, radiographic, and laboratory data were collected from patient records for retrospective study. Ranson score was calculated using data recorded in first 24 hours and 48 hours after admission.
Statistical Analysis
Statistical analyses were performed using SPSS software, version 17 
RESULTS
Mean age at presentation was 59.2 years, and 91 patients (45%) were males. Most frequent AP etiology was biliary, seen in 146 patients (72.3%). Forty patients (19.8%) were diagnosed as having severe AP (organ failure with local complications). Median length of hospital stay was 6 days (range: 3-11 days). Clinical characteristics and outcomes of all patients are summarized in Table 1 .
Median RDW was 14.25% in severe AP group, while patients with mild AP had median RDW of 13.6%. Difference between these 2 groups was statistically significant (p=0.004). Receiver operating characteristic (ROC) curve for initial RDW predicting severe AP yielded area under curve (AUC) of 0.648 (95% CI, 0.55-0.74).
Median Ranson scores were 4 (range: 3-5) and 1 (range: 1-2) for severe AP patients and mild AP patients, respectively. ROC curve for Ranson score predicting severe AP yielded AUC of 0.625 (95% CI, 0.49-0.77).
On basis of highest sensitivity and specificity values generated from ROC curve, ≥4 was selected as cut-off value for Ranson score and 14% was used as RDW limit.
RDW at time of admission (day 0) was correlated with 48-hour Ranson score (r=0.22; p<0.002) (Figure 1 ). At day 0 there was no correlation between RDW and 0-hour Ranson score (r=0.07; p=0.6). 
DISCUSSION
Initial assessment of severity is one of the most important issues in the management of AP. Approximately 15% to 20% of patients with AP develop severe disease, which complicates the clinical course and often causes organ failure. [1] Identifying severity of disease within 24 to 48 hours after admission is essential for planning initial treatment. Our results indicated that RDW level at admission was significantly different between patients with mild or severe AP and was correlated with Ranson's score.
Ranson's criteria were the first widely used severity scoring system, described by John Ranson in 1970s, and included basic laboratory data and clinical variables obtained within 48 hours after hospital admission. [4] Since sensitivity of this score was found to be between 40% and 80%, especially among biliary etiology group, [5] [6] [7] [8] Ranson group developed a modified index. [9] It is still the most common scoring system used to evaluate severity of AP, due to its simplicity. Papachristou et al. [10] compared predictive accuracy of multiparameter score determined by AUC, and found that Ranson score was the only score with AUC >0.9. However, primary disadvantage of this scoring system is need for 48 hours to elapse in order to complete evaluation.
Single prognostic serum markers are widely accepted in clinical use to determine AP severity. Hemoconcentration is acknowledged to be important factor in development of severe AP. Therefore, it could be assumed that hematocrit level on admission could be novel predictor of severity of the disease. Some studies have indicated that hematocrit level over 50% is sign of severity. [11] Other studies carried out in this field have demonstrated hematocrit level over 44% is associated with complications in AP. [12, 13] However, whether changes in hematocrit level during follow-up could be used to assess severity is still unknown. Recent studies have reported that elevated hematocrit level on admission or within first 24 hours is satisfactory single prognostic variable when compared with Ranson criteria and Acute Physiology and Chronic Health Evaluation (APACHE) II system for predicting severity of AP. [11, 12, 14, 15] Creatinine and blood urea nitrogen (BUN) levels are easily measured, and they are routine, inexpensive tests that serve as indicator of acute renal failure. In one study, sensitivity and specificity of BUN elevation to predict severity of AP were determined to be 79% and 70%, respectively. [16] C-reactive protein (CRP) is broadly recognized as indicator of severity 48 hours after disease onset with value greater than 150 mg/dL and other causes of inflammation, such as cholangitis and pneumonia, ruled out. [17] [18] [19] [20] Sensitivity and positive predictive value of serum CRP level in patients with severe AP have been reported to be 83% to 90% and 75% to 86%, respectively, with remarkable increase from onset of AP through first 72 hours. [19] However, CRP level on admission is poor predictor of severity of the disease as result of increased hepatic synthesis due to inflammation-induced cytokine release, and has initial accuracy similar to that of APACHE II score. [7] Interleukin 6 (IL-6) is major mediator of CRP and is released primarily by macrophages. Value measured at admission has sensitivity and specificity of between 69% to 100% and 70% to 86%, respectively, in distinguishing between severe and mild pancreatitis. [21] IL-6 rises with beginning of symptoms and peaks on third day. As it has short plasma half-life, degradation during course of disease can be used as indicator of progression.
IL-8 is a neutrophil-activating cytokine, and can be used as early predictor of severity and complications of AP. [21] Variety of results (sensitivity: 72-100%, specificity: 75-81%) have been reported for prediction of infected necrosis in AP. [22, 23] Despite high prediction rates, however, it still has limited use in daily clinical practice.
IL-10 is a well-known anti-inflammatory cytokine. Though 1 study reported sensitivity of 67% and specificity of 100% with IL-10 for prediction of severity on first day of AP, [24] other studies have stated less reliable results compared with IL-6 and IL-8. [19] Tumor necrosis factor alpha (TNF-α), which is produced primarily by macrophages, is a cytokine that stimulates acute phase reaction. Many clinicians have investigated its role in predicting severity of AP. [25, 26] Unfortunately, outcomes of these studies are not very promising. As result of its rapid clearance, TNF-α is less useful than other cytokines in prediction of severity.
Serum procalcitonin level is known as reliable marker of infection and sepsis. [27] It has 94% sensitivity and 91% specificity rates for detection of infected necrosis in AP. [22] In a review, procalcitonin and relationship to infected necrosis was reported to have overall sensitivity of 80% and specificity of 91%. [28] In an article published in 2006, parallel results were obtained for procalcitonin level over 0.5 ng/mL. [29] Procalcitonin could be recognized as an indicator of infected necrosis, which is one of the major complications that can advance in the progress of AP. However, procalcitonin level is not preferred laboratory data in daily use, which is main handicap of this marker.
Urinary trypsinogen activation peptide (uTAP) is liberated during activation of trypsinogen to trypsin and has been used in recent years to predict severity of AP. According to 1992 Atlanta criteria, uTAP is rapid test that is reliable in prediction of severity of AP. [30] Several studies have demonstrated significant correlation between uTAP level and severity of disease. In a study published in 1997, level of uTAP greater than 10 ng/mL at admission was found to be predictor of severity with sensitivity and specificity rates of 100% and 85%, respectively. [31] Other subsequent studies revealed different sensitivity (58-100%) and specificity (65.8-77%) rates for different uTAP cut-off levels. [32] [33] [34] Meta-analysis determined sensitivity and specificity for uTAP >35 nmol/L of 71% and 75%, respectively (AUC=0.83). [34] Value of uTAP is that it provides useful information about severity at admission, but as it is not widely used in many hospitals, benefit is still limited.
RDW reflects systemic inflammation, and is a remarkable prognostic marker to determine risk of mortality in wide range of clinical manifestations. [35] [36] [37] [38] Şenol et al. [39] demonstrated in their study that increased RDW value at admission was independent predictor of mortality in patients with AP. In this study, high RDW level, i.e., >14.8%, at onset of disease displayed more distinct correlation with non-survival than novel prognostic markers in the literature used to predict mortality.
In conclusion, analysis of CBC panel can provide valuable information, especially for patients with AP. RDW is routine part of CBC. RDW level at admission is helpful to make earlier prediction of severity of AP, especially at first-line centers, considering the disadvantages of multifactorial scoring systems. However, there is no single ideal method to assess severity of the disease. Institutional facilities influence method used for prognostic assessment of AP. Large, multicenter cohort studies are needed.
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